FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.350
-0.010 (-0.74%)
Sep 25, 2026, 10:26 AM EDT - Market open
FibroBiologics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3.52 | 4.89 | 13.99 | 9.16 | 2.27 | 0.41 |
Cash & Short-Term Investments | 3.52 | 4.89 | 13.99 | 9.16 | 2.27 | 0.41 |
Cash Growth | -60.26% | -65.00% | 52.63% | 304.37% | 456.76% | - |
Receivables | 0.4 | - | - | - | 0.3 | - |
Prepaid Expenses | 0.53 | 1.46 | 0.23 | 0.04 | 0.03 | 0.04 |
Other Current Assets | - | - | 0.02 | 0.02 | 0.03 | 0.02 |
Total Current Assets | 5.85 | 6.35 | 14.23 | 9.22 | 2.63 | 0.47 |
Property, Plant & Equipment | 2.03 | 3.22 | 2.22 | 2.61 | 2.2 | - |
Other Long-Term Assets | 0.05 | 0.05 | - | - | - | - |
Total Assets | 7.93 | 9.62 | 16.45 | 11.82 | 4.82 | 0.47 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.82 | 0.95 | 2.7 | 1.44 | 0.76 | 0.23 |
Short-Term Debt | 0.12 | - | 9.17 | - | 5.45 | 1.53 |
Current Portion of Leases | 0.26 | 0.71 | 0.4 | 0.36 | 0.33 | - |
Other Current Liabilities | 0.01 | 0.11 | 0.46 | 7.38 | 0.54 | - |
Total Current Liabilities | 2.21 | 1.76 | 12.73 | 9.18 | 7.07 | 1.76 |
Long-Term Leases | 1.08 | 1.7 | 0.98 | 1.39 | 1.75 | - |
Total Liabilities | 3.29 | 3.46 | 13.71 | 10.57 | 8.82 | 1.76 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | - | 0 | 0 | - |
Additional Paid-In Capital | 67.92 | 60.32 | 38.25 | 25.61 | 2.41 | - |
Retained Earnings | -63.28 | -54.16 | -35.52 | -24.36 | -7.87 | -2.75 |
Comprehensive Income & Other | - | - | - | - | 1.46 | 1.46 |
Shareholders' Equity | 4.64 | 6.16 | 2.74 | 1.25 | -4 | -1.29 |
Total Liabilities & Equity | 7.93 | 9.62 | 16.45 | 11.82 | 4.82 | 0.47 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1.46 | 2.41 | 10.55 | 1.75 | 7.52 | 1.53 |
Net Cash (Debt) | 2.05 | 2.48 | 3.43 | 7.42 | -5.26 | -1.12 |
Net Cash Growth | - | -27.62% | -53.72% | - | - | - |
Net Cash Per Share | 0.54 | 1.11 | 2.09 | 5.25 | -3.73 | -2.56 |
Filing Date Shares Outstanding | 6.66 | 3.38 | 1.89 | 1.62 | 28.23 | 40.73 |
Total Common Shares Outstanding | 6.08 | 3.33 | 1.75 | 28.23 | 28.23 | 40.73 |
Working Capital | 3.64 | 4.59 | 1.5 | 0.03 | -4.45 | -1.29 |
Book Value Per Share | 0.76 | 1.85 | 1.56 | 0.04 | -0.14 | -0.03 |
Tangible Book Value | 4.64 | 6.16 | 2.74 | 1.25 | -4 | -1.29 |
Tangible Book Value Per Share | 0.76 | 1.85 | 1.56 | 0.04 | -0.14 | -0.03 |
Machinery | 1.29 | 1.29 | 1.03 | 0.84 | - | - |